Monday, June 15, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 948 of 1,261

  1. US 8039489

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  2. US 8039585

    Therapeutic administration of the scrambled anti-angiogenic peptide C16Y

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  3. US 8039491

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  4. US 8039593

    Antibodies and immunotoxins that target human glycoprotein NMB

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  5. US 8039257

    Pre-transplant accomodated organs resistant to anti-donor immunity

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  6. US 8038997

    Anti-marinobufagenin antibodies and methods for their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  7. US 8039008

    Identification of residues critical for the function of the vibrio cholerae virulence regulator ToxT by scanning alanine mutagenesis

    The Board of Regents of the University of Texas System · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  8. US 8039003

    Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  9. US 8039661

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  10. DE 102010014113

    Freisetzungsverfahren für Implantate

    ACINO AG [DE] · Granted Oct 13, 2011 · Expires Oct 8, 2031

    granted

  11. DE 202010004750

    Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut

    BIOFRONTERA BIOSCIENCE GMBH [DE] · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  12. US 8034832

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  13. US 8034946

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  14. US 8034950

    Processes for the facile synthesis of diaryl amines and analogues thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  15. US 8034329

    Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells

    Advanced Technologies and Regenerative Medicine, LLC · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  16. US 8034812

    Imidazopyridazine derivative having kinase inhibitory activity and pharmaceutical agent thereof

    Takeda Pharmaceutical Company Limited · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  17. US 8034768

    Composition and method for the treatment of diseases affected by histone deacetylase inhibitors

    The Board of Regents of the University of Texas System · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  18. US 8034376

    Lipid containing formulations

    Alnylam Pharmaceuticals, Inc. · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  19. US 8034334

    Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  20. US 8034826

    Cycloalkane[B]azaindole antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  21. US 8034825

    Chemically modified small molecules

    Nektar Therapeutics · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  22. US 8034821

    Selective serine/threonine kinase inhibitors

    The Regents of the University of California · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  23. US 8034822

    Glucokinase activators

    Takeda San Diego, Inc. · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  24. US 8034384

    Method of increasing biocompatibility of medical device by generating nitric oxide

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.